Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Letrozole × Clear all

Sponsor

Conditions

Breast Neoplasms 92 Neoplasm Metastasis 5 Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 4 Breast Neoplasms, Male 4 Arthralgia 4 Triple Negative Breast Neoplasms 2 Polycystic Ovary Syndrome 2 Pain 2 Ovarian Neoplasms 2 Osteoporosis 2 Leiomyosarcoma 2 Leiomyoma 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Recurrence 1 Ovarian Cysts 1 Osteitis Deformans 1 Obesity 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphoma, Non-Hodgkin 1 Lymphangioleiomyomatosis 1 Lethal Congenital Contracture Syndrome 2 1 Infertility 1 Hormone-sensitive Metastatic Breast Cancer 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Fractures, Bone 1

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡